International Journal of Antimicrobial Agents Emergent and Evolving Antimicrobial Resistance Cassettes in Community-associated Fusidic Acid and Meticillin-resistant Staphylococcus Aureus
暂无分享,去创建一个
J. Parkhill | S. Harris | S. Peacock | M. Holden | C. Köser | M. Ellington | E. Cartwright | D. Greaves | S. Gerver | R. Hope | S. Reuter | M. Estée Török | Nicholas M Brown
[1] S. Monecke,et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Julian Parkhill,et al. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community , 2014, Proceedings of the National Academy of Sciences.
[3] P. Hsueh,et al. A Novel Staphylococcal Cassette Chromosomal Element, SCCfusC, Carrying fusC and speG in Fusidic Acid-Resistant Methicillin-Resistant Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.
[4] Anne M Johnson,et al. Use of Primary Care Data for Detecting Impetigo Trends, United Kingdom, 1995–2010 , 2013, Emerging infectious diseases.
[5] D. Coleman,et al. Staphylococcal cassette chromosome mec: recent advances and new insights. , 2013, International journal of medical microbiology : IJMM.
[6] S. Monecke,et al. Prevalence and characteristics of community carriage of methicillin-resistant Staphylococcus aureus in Malta , 2013, Journal of epidemiology and global health.
[7] B. Kreiswirth,et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). , 2012, Current opinion in microbiology.
[8] Chien-Lin Liu,et al. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus. , 2012, International journal of antimicrobial agents.
[9] Julian Parkhill,et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. , 2012, The New England journal of medicine.
[10] Matthew Berriman,et al. Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data , 2011, Bioinform..
[11] S. Monecke,et al. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region , 2011, BMC Microbiology.
[12] Stephen D. Bentley,et al. A Very Early-Branching Staphylococcus aureus Lineage Lacking the Carotenoid Pigment Staphyloxanthin , 2011, Genome biology and evolution.
[13] M. Castanheira,et al. Characterization of global patterns and the genetics of fusidic acid resistance. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. Chen,et al. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital , 2011, BMC Microbiology.
[15] A. Carmichael,et al. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[16] Ronald N. Jones,et al. Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008 , 2010, Antimicrobial Agents and Chemotherapy.
[17] N. Brown,et al. Community-associated methicillin-resistant Staphylococcus aureus infections. , 2010, British medical bulletin.
[18] A. Pearson,et al. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. , 2009, The Journal of antimicrobial chemotherapy.
[19] C. Palmer,et al. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use. , 2007, International journal of antimicrobial agents.
[20] Alexandros Stamatakis,et al. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models , 2006, Bioinform..
[21] N. McCallum,et al. Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Zürich, Switzerland (2003): Prevalence of Type IV SCCmec and a New SCCmec Element Associated with Isolates from Intravenous Drug Users , 2005, Journal of Clinical Microbiology.
[22] R. Lynfield,et al. Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.
[23] B. Barrell,et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Livermore,et al. Fusidic-acid use and resistance , 2002, The Lancet.
[25] Robert S. Daum,et al. Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2002, Antimicrobial Agents and Chemotherapy.
[26] D. Spelman. Fusidic acid in skin and soft tissue infections. , 1999, International journal of antimicrobial agents.
[27] Antibiotic resistance and topical treatment. , 1978, British medical journal.
[28] R. Howe,et al. BSAC standardized disc susceptibility testing method (version 10). , 2011, The Journal of antimicrobial chemotherapy.